EPI was created in 2006 to facilitate interdisciplinary studies of emergence and control of human, animal and plant pathogens of concern to the world.
EPI collaborates with over 250 faculty members from around the world annually.
Nov. 6, 2019: New research from the EPI and UF’s College of Public Health & Health Professions found that exposing the sexually-transmitted bacterial pathogen Chlamydia to fosmidomycin — an antibiotic which is usually lethal to bacteria — causes Chlamydia to enter a protective bunker-like “persistent” state. The findings could bolster future efforts to intentionally disrupt the molecular changes that induce chlamydial persistence, leading to the prevention of chronic chlamydial infections. Read More
Oct. 21, 2019: New research by EPI investigator KC Jeong looks at how a host’s genetic background strongly influences the composition and development of its gut microbiota. Read More
October 17, 2019: When Hurricanes Irma and Maria lashed the Caribbean in 2017, the U.S. Virgin Islands experienced devastation similar to Puerto Rico, including massive disruption to their healthcare system, but with less media fanfare. The extent of damage unleashed by these storms on medical care in the U.S. Virgin Islands is only now coming into focus, thanks to research by UF's Emerging Pathogens Institute Director J. Glenn Morris and College of Medicine Interim Dean Adrian Tyndall. Read More
October 7, 2019: New modeling by EPI researcher Burton Singer calculates that the substantial costs involved in developing a universal flu vaccine are worth every cent. Singer collaborated with a team from Yale University, University of Texas at Austin, and the University of Maryland to calculate that a universal flu vaccine would save $3.5 billion in direct medical costs annually and save 19,500 lives in the U.S. alone. Read More
Sept. 30, 2019: A new $1.29 million grant from the Global Health Innovative Technology Fund will support EPI malaria investigator Rhoel Dinglasan’s work to develop a novel saliva-based malaria diagnostic test that catches infections even when victims don’t show symptoms. Read More
November 19, 2019: Mustafizur Rahman, PhD, is the Head of Virology Laboratory and a Senior Scientist in Infectious Diseases Division at International Centre for Diarrhoeal Disease Research, Bangladesh. He completed BS and MS in Microbiology from University of Dhaka in Bangladesh and received his PhD in Virology from University of Leuven in Belgium in 2008. He completed a postdoctoral fellowship in EPI during 2013-14. Read More
Jan Powell, PhD, MPH, currently works as a Senior Scientist for the Institute of Environmental Science and Research (ESR) in New Zealand. She is a member of Risk Assessment and Social Systems team lead by Dr. Rob Lake, with a focus on public health risk analysis of microbiological and chemical hazards in food and drinking water. Jan received her MSc and PhD from the University of Otago, in the laboratory of Prof. Margaret Loutit studying the prevalence and pathogenesis of fish pathogen Vibrio anguillarum in the environment and salmon. Read More
October 1, 2019: Ellen Knuepfer, PhD, works as a Principal Laboratory Research Scientist and later this year will establish a new group at the Royal Veterinary College. She started her career with a PhD from Imperial College, in Deborah F. Smith’s laboratory studying proteins essential for Leishmania transmission. Read More
Nick Keiser, PhD, is an assistant professor in the Department of Biology at the University of Florida. He received his PhD in Ecology and Evolution from the University of Pittsburgh and completed a postdoctoral fellowship in the Academy of Fellows at Rice University. Read More
September 10, 2019: Mohammad Shahnoor Hossain, PhD is currently working as a faculty member at the University of Dhaka, Bangladesh. His research focuses on genotypic and phenotypic characterization of oral streptococci. Read More